Clinical,biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab

Abstract

Systemic lupus erythematosus (SLE) is a multiorganic autoimmune disease that affects skin, osteoarticular and kidney frequently. Rituximab showed efficacy in treatment of osteoarticular and haematological SLE, but its use has been generalised for renal disease. In our case, we showed efficacy of rituximab in SLE articular disease, showing an ultrasonographic improvement.

Keywords

anti-DNA antibodies musculoskeletal systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

1 Zoma A . Musculoskeletal involvement in systemic lupuserythematosus. Lupus 2004; 13: 851–853.

2 Smith KG Jones RB Burns SM Jayne DR . Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and retreatment. Arthritis Rheum 2006; 54: 2970–2982.

3 Leandro MJ Cambridge G Edwards JC Ehrenstein MR Isenberg DA . B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) 2005; 44: 1542–1545 Epub 2005 Sep 27.

4 Cohen SB Emery P Greenwald MW . REFLEX Trial Group. Rituximab for rheumatoid arthritis refractory to anti-tumour necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006; 54: 2793–2806.

5 Wakefield RJ Balint PV Szkudlarek M . OMERACT 7 Special Interest Group. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005; 32: 2485–2487.

6 Naredo E Bonilla G Gamero F Uson J Carmona L Lafon A . Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 2005; 64: 375–381.

7 Naredo E Collado P Cruz A . Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum 2007; 57: 116–124.

8 Ozgocmen S Kiris A Kocakoc E Ardicoglu O Kamanli A . Evaluation of metacarpophalangeal joint synovitis in rheumatoid arthritis by power Doppler technique: relationship between synovial vascularization and periarticular bone mineral density. Joint Bone Spine 2004; 71: 384–388.

9 Walther M Harms H Krenn V Radke S Faehndrich TP Gohlke F . Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2001; 44: 331–338.

10.

10 Walther M Harms H Krenn V Radke S Kirschner S Gohlke F . Synovial tissue of the hip at power Doppler US: correlation between vascularity and power Doppler US signal. Radiology 2002; 225: 225–231.

11.

11 Ribbens C André B Marcelis S . Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study. Radiology 2003; 229: 562–569.

12.

12 Filippucci E Iagnocco A Salaffi F Cerioni A Valesini G Grassi W . Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis 2006; 65: 1433–1437.

13.

13 Wright S Filipucci E Grassi W Grey A Bell A . Hand arthritis in systemic lupus erythematosus: an ultrasound pictorial essay. Lupus 2006; 15: 501–506.

14.

14 Iagnocco A Ossandon A Coari G . Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. Clin Exp Rheumatol 2004; 22: 621–624.

15.

15 Gottenberg JE Guillevin L Lambotte O . Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 2005; 64: 913–920.